Revenue, 2025
USD 6.19 Bn
Forecast Year, 2034
USD 40.34 Bn
CAGR, 2025 - 2034
23.02%
Report Coverage
Worldwide
The global single-cell omics market, valued at USD 6.19 billion in 2025, is poised to surge to USD 40.34 billion by 2034, driven by a robust CAGR of 23.02%, fueled by advances in genomics, proteomics, and personalized medicine research.
Single-cell Omics Market Size Analysis
Single-cell Omics Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Single-Cell Genomics | 1.48 | 1.77 | 2.19 | 2.91 | 3.53 | 4.53 | 5.55 | 7.09 | 7.90 | 9.59 |
| Single-Cell Proteomics | 1.62 | 1.94 | 2.44 | 2.94 | 3.69 | 4.40 | 5.66 | 6.64 | 8.49 | 9.99 |
| Single-Cell Metabolomics | 1.56 | 1.85 | 2.07 | 2.45 | 3.03 | 3.67 | 4.27 | 5.49 | 7.14 | 9.25 |
| Single-Cell Transcriptomics | 1.53 | 2.06 | 2.68 | 3.22 | 3.92 | 4.84 | 5.98 | 7.17 | 8.94 | 11.11 |
Single-cell Omics Market Size By Application 2025 to 2034 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunology | 1.51 | 1.77 | 2.01 | 2.41 | 2.96 | 3.71 | 4.50 | 5.52 | 6.50 | 8.75 |
| Cell Biology | 1.63 | 2.09 | 2.66 | 3.14 | 3.81 | 4.80 | 6.03 | 7.43 | 8.96 | 11.18 |
| Oncology | 1.51 | 1.88 | 2.28 | 3.04 | 3.56 | 4.10 | 4.67 | 5.42 | 7.01 | 8.08 |
| Neurology | 1.54 | 1.88 | 2.42 | 2.92 | 3.85 | 4.83 | 6.26 | 8.03 | 10.01 | 11.93 |
Single-cell Omics Market Size By End-User 2025 to 2034 (USD Billion)
| End-User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital and Diagnostic Laboratories | 1.63 | 1.98 | 2.38 | 2.92 | 3.74 | 4.68 | 5.57 | 7.20 | 8.33 | 10.84 |
| Academic and Research Organizations | 1.45 | 1.83 | 2.27 | 2.65 | 3.38 | 3.89 | 4.94 | 5.96 | 7.14 | 8.67 |
| Pharmaceutical & Biotechnology Companies | 1.61 | 1.96 | 2.52 | 3.00 | 3.68 | 4.48 | 5.83 | 7.12 | 8.98 | 11.18 |
| Others | 1.51 | 1.85 | 2.20 | 2.95 | 3.38 | 4.39 | 5.12 | 6.12 | 8.03 | 9.26 |
Single-cell Omics Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.37 | 1.75 | 2.19 | 2.58 | 3.30 | 3.99 | 5.06 | 6.17 | 7.91 | 10.28 |
| Europe | 1.26 | 1.47 | 1.79 | 2.41 | 2.85 | 3.74 | 4.23 | 5.35 | 6.36 | 8.15 |
| Asia Pacific | 1.19 | 1.42 | 1.86 | 2.35 | 2.84 | 3.20 | 4.00 | 5.16 | 6.80 | 7.71 |
| Latin America | 1.14 | 1.34 | 1.57 | 1.90 | 2.41 | 3.27 | 3.92 | 4.72 | 5.77 | 7.61 |
| Middle East and Africa | 1.23 | 1.62 | 1.96 | 2.30 | 2.78 | 3.24 | 4.25 | 4.99 | 5.63 | 6.19 |
Single-cell Omics Market Size to Attain USD 40.34 Billion by 2034
The global single-cell omics market size accounted for USD 6.19 billion in 2025 and is predicted to touch around USD 40.34 billion by 2034 a CAGR of 23.02%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com